Status:
COMPLETED
Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study)
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The National Heart, Lung, and Blood Institute (NHLBI) has established guidelines for treating people with asthma. This study will evaluate the effectiveness of a distance learning program that aims to...
Detailed Description
Asthma is a long-term lung disease that affects more than 22 million people in the United States. Symptoms include wheezing, chest tightness, shortness of breath, and coughing. Inhaled corticosteroids...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Board-eligible pediatricians involved in direct primary care for children
- Has access to a Windows or Macintosh computer with either a CD-ROM drive or Internet access
- Has access to a telephone for teleconference calls
- Willing to take part in the DALI educational seminar if assigned to the intervention group
Exclusion
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00815724
Start Date
February 1 2007
End Date
March 1 2008
Last Update
March 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94118